Trial intelligence / Profile preview

iCARE: Improving the Quality of Care for Asthma Patients at Risk of Exacerbations

NCT06596512Not yet recruiting

Sponsor
Brigham and Women's Hospital
Start
Jul 2026
Primary completion
May 2030
Countries
1
01

Overview

Randomised, open-label trial in asthma (4 arms), sponsored by Brigham and Women's Hospital. Primary endpoint: Asthma Exacerbations at 16 months. Planned start Jul 2026; status: not yet recruiting.

02

Conditions

asthma

Beyond the preview

Go deeper on NCT06596512.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT06596512.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call